(Reuters) -Dialysis firm DaVita reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs.
Shares of the company were down 7.1% at $147 after the bell.
On an adjusted basis, it reported third-quarter profit of $2.59 per share, below analysts’ estimate of $2.73 per share, as per data compiled by LSEG.
The company reiterated its annual profit forecast of $9.25 and $10.05 per share.
DaVita posted quarterly revenue of $3.26 billion, largely in line with analysts’ estimates of $3.25 billion.
DaVita provides kidney care services to patients suffering from chronic kidney failure in the United States through a network of outpatient clinics and at-home dialysis services.
(Reporting by Sneha S K; Editing by Maju Samuel)
